LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $465,000 | -63.5% | 76,282 | -29.7% | 0.00% | -75.0% |
| Q1 2019 | $1,274,000 | +141.3% | 108,441 | +31.6% | 0.01% | +166.7% |
| Q4 2018 | $528,000 | -58.6% | 82,419 | -24.0% | 0.00% | -62.5% |
| Q3 2018 | $1,274,000 | -6.1% | 108,441 | -0.9% | 0.01% | -11.1% |
| Q2 2018 | $1,357,000 | +50.9% | 109,441 | +1.9% | 0.01% | +50.0% |
| Q1 2018 | $899,000 | -56.9% | 107,441 | -25.1% | 0.01% | -62.5% |
| Q4 2017 | $2,084,000 | 0.0% | 143,441 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $2,084,000 | -11.9% | 143,441 | 0.0% | 0.02% | -15.8% |
| Q2 2017 | $2,365,000 | +221.8% | 143,441 | +177.2% | 0.02% | +137.5% |
| Q2 2016 | $735,000 | +33.9% | 51,741 | +15.9% | 0.01% | +33.3% |
| Q1 2016 | $549,000 | -22.1% | 44,641 | -15.4% | 0.01% | -25.0% |
| Q4 2015 | $705,000 | +25.9% | 52,741 | +1.2% | 0.01% | +14.3% |
| Q3 2015 | $560,000 | +36.9% | 52,141 | +2.6% | 0.01% | +40.0% |
| Q2 2015 | $409,000 | – | 50,841 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |